Honorable Jaime Capelo, Chair, House Committee on Public Health
FROM:
John Keel, Director, Legislative Budget Board
IN RE:
HB3138 by Wilson (Relating to the classification of ephedra as a dangerous drug.), As Introduced
No fiscal implication to the State is anticipated.
The bill would amend Section 483.001 (2) of Chapter 483, Dangerous Drugs, Health and Safety Code, to classify ephedra as a dangerous drug. The Department of Health would continue to license food manufacturers, under the assumption these manufacturers would no longer make dietary supplements with ephedra, which creates no fiscal impact to the Department.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies:
405 Department of Public Safety, 501 Department of Health